Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Trend and risk factors of drug resistance tuberculosis between 2005-2012 in Istanbul, Turkey

Aylin Babalik, Sinem Koyman, Aysegül Yildirim, Zeki Kiliçaslan
European Respiratory Journal 2015 46: PA2742; DOI: 10.1183/13993003.congress-2015.PA2742
Aylin Babalik
1Pulmonary, Süreyyapasa Hospital, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sinem Koyman
2Tuberculosis Branch, Istanbul Publich Health Directorate, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aysegül Yildirim
3Department of Tuberculosis, Publich Health Directorate, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zeki Kiliçaslan
4Pulmonary Department, Istanbul University, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

The proportion of drug-resistant TB cases is a useful indicator for assessing the performance of a TB control programme. The aim of this study is thus to Detection of prevalence and trend resistance and evaluate risk factors for any drug-resistant TB and MDR-TB in Istanbul, Turkey between 2005-2012.

Methods: This study is a retrospective cohort study involving tuberculosis patients receiving treatment between 1st January 2005 and 31st December 2012 carried out at TB dispensaries in Istanbul. Patients who were not tested culture methods (n=20.365), patients who had culture negative (n=5413). In patients who had culture positive (n=19.775), patients had not tested DST (n=2654). Patients who were tested with TB drug susceptibility were analyzed (n=17.121).

Results: Rating TB population tested for drug susceptibility was seen increasing (24.0% vs 47.6 %). Rating any drug resistance; in total cases (11.7% vs 15.9%), in previous treated cases (25.6% vs 34.9%), Rating MDR; in total cases (5.6% vs 6.2%), in previous treated cases (16.4 % vs 23.1%) was increasing. Any drug resistance was significantly high (AOR (1.43 (1.18–1.75)) in 2012 according to 2005. In other country birth, Any drug resistance (AOR (2.21 (1.69–2.89)), MDR (AOR (3.36 (2.41-4.70)) was found significantly high. In previous treated history, Any drug resistance (AOR (3.18 (2.85-3.54)), MDR-TB (AOR (6.70 (5.82-7.72)) was found significant in previous treated history.

Conclusion: Rating TB population tested for drug susceptibility is increasing by years. Information remains incomplete in the world. Other country birth and previous treatment history should be more closely follow up.

  • MDR-TB
  • Treatments
  • Tuberculosis - management
  • Copyright ©ERS 2015
Previous
Back to top
Vol 46 Issue suppl 59 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Trend and risk factors of drug resistance tuberculosis between 2005-2012 in Istanbul, Turkey
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Trend and risk factors of drug resistance tuberculosis between 2005-2012 in Istanbul, Turkey
Aylin Babalik, Sinem Koyman, Aysegül Yildirim, Zeki Kiliçaslan
European Respiratory Journal Sep 2015, 46 (suppl 59) PA2742; DOI: 10.1183/13993003.congress-2015.PA2742

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Trend and risk factors of drug resistance tuberculosis between 2005-2012 in Istanbul, Turkey
Aylin Babalik, Sinem Koyman, Aysegül Yildirim, Zeki Kiliçaslan
European Respiratory Journal Sep 2015, 46 (suppl 59) PA2742; DOI: 10.1183/13993003.congress-2015.PA2742
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany
  • Tuberculosis-specific CD8 cells in HLA A*02-positive TB and LTBI patients
  • Markers of cellular immunity in the diagnosis of tuberculosis pleurisy
Show more 10.2 Tuberculosis

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society